​
​

Praxis Precision Medicines Ownership | Who Owns Praxis Precision Medicines?

OverviewForecastRevenueFinancialsChartTranscripts

Praxis Precision Medicines Ownership Summary

Praxis Precision Medicines is owned by 0.34% institutional investors, and 99.66% retail investors. American Funds SMALLCAP World A is the top mutual fund, with 5.00% of its assets in Praxis Precision Medicines shares.

PRAX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPraxis Precision Medicines0.34%-99.66%
SectorHealthcare Stocks 46.98%7.90%45.12%
IndustryBiotech Stocks 44.85%7.67%47.48%

Institutional Shareholders

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 20232-97.37%460,519-99.60%-0.00%--100.00%2-90.00%
Sep 30, 202376-1.30%114,399,484-2.21%1640.34%33-13.16%20-20.00%
Jun 30, 202377-13.48%116,984,506119.92%2202.20%38-25.49%2525.00%
Mar 31, 202389-15.24%53,194,90416.78%1001.03%518.51%20-47.37%
Dec 31, 2022105-45,551,3428.28%981.17%47-9.62%3818.75%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
American Funds SMALLCAP World A888.06K5.00%888.06K
Vanguard Total Stock Mkt Idx Inv541.27K3.05%-
iShares Russell 2000 ETF443.91K2.50%-994.00
US Small-Cap Growth II Equity Comp418.72K2.36%154.21K
T. Rowe Price New Horizons418.72K2.36%-1.32K
SPDR® S&P Biotech ETF389.92K2.20%4.32K
Franklin Biotechnology Discv A(acc)USD282.19K1.59%28.00K
Fidelity Select Biotechnology273.41K1.54%-17.40K
Vanguard Institutional Extnd Mkt Idx Tr254.31K1.43%-3.65K
Renaissance Global Health Care192.30K1.08%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 05, 2023DeSimone Jill-Buy$25.38K
Jun 27, 2023Souza Marcio Chief Executive OfficerBuy$10.59K
Mar 24, 2023Kelly Timothy Edwin Chief Financial OfficerBuy$7.00K
Mar 23, 2023Souza Marcio Chief Executive OfficerBuy$30.21K
Mar 23, 2023Souza Marcio Chief Executive OfficerBuy$30.16K

Insider Transactions Trends

DateBuySell
2024 Q3--
2024 Q2--
2024 Q1--
2023 Q41-
2023 Q21-

PRAX Ownership FAQ

Who Owns Praxis Precision Medicines?

Praxis Precision Medicines shareholders are primarily institutional investors at 0.34%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Praxis Precision Medicines's industry, Biotech Stocks , is 44.85%, which Praxis Precision Medicines falls below.

Does Blackrock own Praxis Precision Medicines?

BlackRock is not among the top 10 institutional shareholders of Praxis Precision Medicines.

Who is the top mutual fund holder of Praxis Precision Medicines shares?

American Funds SMALLCAP World A is the top mutual fund holder of Praxis Precision Medicines shares, with 5.00% of its total shares outstanding invested in 888.06K Praxis Precision Medicines shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools